Most cited papers from Cytovac (Denmark)

Cytovac (Denmark)

What are the most cited papers from Cytovac (Denmark)?

The most cited paper from Cytovac (Denmark) is "Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells" (Alexei F. Kirkin, Karine N. Dzhandzhugazyan, Per Guldberg et al., 2018), with 52 citations. Next come "Adoptive T cell cancer therapy" (27) and "Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis" (15).

Published FieldAccess

Showing 6 of 6 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells Alexei F. Kirkin, Karine N. Dzhandzhugazyan, Per Guldberg et al. · Nature Communications Open access	19 Feb 2018	52
2	Adoptive T cell cancer therapy Karine N. Dzhandzhugazyan, Per Guldberg, Alexei F. Kirkin · Nature Materials	15 May 2018	27
3	Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis Odd Lilleng Gammelgaard, Mikkel G. Terp, Alexei F. Kirkin et al. · Molecular Cancer Open access	6 Jan 2024	15
4	Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition Mie K. Jakobsen, Sofie Traynor, Aaraby Nielsen et al. · Journal of Experimental & Clinical Cancer Research Open access	23 Jan 2025	11
5	A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma Katja Werlenius, Giuseppe Stragliotto, Michael Strandéus et al. · Neuro-Oncology Advances Open access	2021	10
6	Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial Odd Lilleng Gammelgaard, Sidse Ehmsen, Anne Marie Bak Jylling et al. · Journal for ImmunoTherapy of Cancer Open access	Dec 2025	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.